Journal
CELL STEM CELL
Volume 6, Issue 6, Pages 513-516Publisher
CELL PRESS
DOI: 10.1016/j.stem.2010.05.008
Keywords
-
Categories
Ask authors/readers for more resources
Cell therapies derived from pluripotent stem cells are entering the preclinical and early clinical development phase, but eventual translation faces many challenges. We describe a new approach by California to form global public-private disease team partnerships to enable new clinical opportunities to be evaluated in the complex regulatory environment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available